These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2903346)
1. Ganciclovir for severe cytomegalovirus infection in transplant recipients. Rostoker G; Ben Maadi A; Buisson C; Deforge L; Weil B; Lang P Lancet; 1988 Nov; 2(8620):1137-8. PubMed ID: 2903346 [No Abstract] [Full Text] [Related]
2. Ganciclovir for severe cytomegalovirus infection in transplant recipients. Nicholson ML; Flower AJ; Simpson A; Donnelly PK; Veitch PS; Bell PR Lancet; 1988 Dec 24-31; 2(8626-8627):1501-2. PubMed ID: 2904627 [No Abstract] [Full Text] [Related]
3. DHPG treatment of kidney transplant recipients with severe CMV infection. Lang P; Buisson C; Rostoker G; Ben Maadi A; Fruchaud G; Deforge L; Chopin D; Abbou C; Romano P; Fleury J Transplant Proc; 1989 Feb; 21(1 Pt 2):2084-6. PubMed ID: 2540560 [No Abstract] [Full Text] [Related]
4. Treatment of cytomegalovirus infections in renal transplant recipients with 9-(1,3-dihydroxy-2-propoxymethyl) guanine. Cantarovich M; Hiesse C; Lantz O; Fassi-Fihri S; Charpentier B; Fries D Transplantation; 1988 Jun; 45(6):1139-41. PubMed ID: 2837848 [No Abstract] [Full Text] [Related]
12. Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts. Erice A; Jordan MC; Chace BA; Fletcher C; Chinnock BJ; Balfour HH JAMA; 1987 Jun; 257(22):3082-7. PubMed ID: 3035246 [TBL] [Abstract][Full Text] [Related]
13. Ganciclovir for treatment of cytomegalovirus disease. Jordan MC DICP; 1989 Jan; 23(1):85-6. PubMed ID: 2541567 [No Abstract] [Full Text] [Related]
14. Successful treatment of severe cytomegalovirus infections with ganciclovir and CMV hyperimmune globulin in liver transplant recipients. D'Alessandro AM; Pirsch JD; Stratta RJ; Sollinger HW; Kalayoglu M; Belzer FO Transplant Proc; 1989 Jun; 21(3):3560-1. PubMed ID: 2545018 [No Abstract] [Full Text] [Related]
15. Early selection of a new UL97 mutant with a severe defect of ganciclovir phosphorylation after valaciclovir prophylaxis and short-term ganciclovir therapy in a renal transplant recipient. Hantz S; Michel D; Fillet AM; Guigonis V; Champier G; Mazeron MC; Bensman A; Denis F; Mertens T; Dehee A; Alain S Antimicrob Agents Chemother; 2005 Apr; 49(4):1580-3. PubMed ID: 15793144 [TBL] [Abstract][Full Text] [Related]
16. Successful use of oral valacyclovir in post-transplant cytomegalovirus infection in renal allograft recipients. Himmelmann-Jud B; Wüthrich RP; Weinreich T; Binswanger U Nephrol Dial Transplant; 1998 May; 13(5):1326-7. PubMed ID: 9623588 [No Abstract] [Full Text] [Related]
17. [Treatment of disseminated cytomegalovirus infection with ganciclovir in a patient with acquired immunodeficiency syndrome]. Niiya K; Hirose S; Miyoshi I Nihon Naika Gakkai Zasshi; 1989 May; 78(5):686-7. PubMed ID: 2549136 [No Abstract] [Full Text] [Related]
18. Ganciclovir--have we established clinical value in the treatment of cytomegalovirus infections? Whitley RJ Ann Intern Med; 1988 Mar; 108(3):452-4. PubMed ID: 2829680 [No Abstract] [Full Text] [Related]
19. Cytomegalovirus pneumonia: the use of ganciclovir in marrow transplant recipients. Ettinger NA; Selby P; Powles R; Milliken S; Gallagher C; Jameson B; Tryhorn Y; Stern H J Antimicrob Chemother; 1989 Jul; 24(1):53-62. PubMed ID: 2550414 [TBL] [Abstract][Full Text] [Related]
20. [Ganciclovir and infections caused by the cytomegalic inclusion virus]. Roy C Med Clin (Barc); 1989 Feb; 92(6):220-2. PubMed ID: 2540386 [No Abstract] [Full Text] [Related] [Next] [New Search]